

Sutherlandia frutescens is a shrub native to South Africa and the coast of West Africa. This plant and related species have been used by the locals as medicine to treat diabetes, chicken pox, and external wounds. Although Sutherlandia is not generally consumed as a dietary supplement in the West, some use the raw herb as an adaptogen. Constituents in Sutherlandia have antiviral, antibacterial, antifungal and anticancer properties (2). Sutherlandia is also known as “Cancer bush” for its purported use as a cancer treatment. There are case reports of Sutherlandia's ability to reduce fatigue in cancer patients (3).
In recent years, there is a growing effort in Africa to promote the use of local herbs to treat AIDS due to the lack of pharmaceuticals but easy access to traditional medicines. Based on reports that Sutherlandia is effective against HIV virus (4), it has been proposed as a treatment for AIDS (5). A study is currently underway to test the safety and efficacy of this herb in HIV-infected adults (6).
Adverse effects are rare but Sutherlandia may inhibit P-glycoprotein and cytochrome P450 3A4 and can interact with other substrate drugs, particularly those used to treat AIDS (7) (8).
Sutherlandia was shown to have antioxidant and anti-inflammatory effects in vitro (9). The active components of the plant are L-canavanine, Pinitol, GABA, and novel triterpenoid glucoside. Pinitol demonstrates antidiabetic effects by increasing the availability of glucose for cell metabolism (2). GABA found in dry leaves of Sutherlandia can slow down nerve cell activity (2).
The ethanolic extract of Sutherlandia inhibits growth of MCF-7 breast adenocarcinoma cell line by inducing apoptosis (10) (11). Sutherlandia downregulates metalloproteinases (MMP) that control cell migration, proliferation, apoptosis, and regulate tumor expansion, angiogenesis and dissemination (10).
Common: Diarrhea, dry mouth, dizziness.
Rare: Drinking or swallowing high doses of Sutherlandia may cause sweating and vomiting (2).
Johnson Q, Syce J, Nell H, et al. A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults. PLoS Clin Trials. 2007;2(4):e16.
This is the first clinical trial of Sutherlandia conducted to determine its toxicity and hemotological effects. Twenty-five healthy adults were randomized to consume either Sutherlandia leaf powder 800mg daily or a placebo. After 3 months, the Sutherlandia group reported better appetite. No other clinically significant differences were found between the two groups.
Further studies are needed to determine the efficacy of Sutherlandia products.
Bottom line: Laboratory studies indicate anticancer effects of Sutherlandia frutescens, but it has not been shown to treat or prevent cancer in humans.
Sutherlandia frutescens is a shrub native to Southern Africa and along the coast of West Africa. It is used in traditional medicine to treat diabetes, chicken pox, and external wounds, and also as a cancer treatment. Laboratory studies show that Sutherlandia can fight off viruses, bacteria, fungi, and also has anticancer properties. A few case reports show that it can decrease fatigue in cancer patients.
Because Sutherlandia can fight HIV virus, it is being proposed as an AIDS treatment in Africa. Clinical trials are needed to determine Sutherlandia's safety and efficacy.
Common: Diarrhea, dry mouth, dizziness.
Rare: Drinking or swallowing high doses of Sutherlandia may cause sweating and vomiting.